WHO multicenter evaluation of FACSCount CD4 and Pima CD4 T-cell count systems: Instrument performance and misclassification of HIV-infected patients

Journal of Acquired Immune Deficiency Syndromes

Volumn 66, Issue 5, 2014, Pages

  Wade, Djibril ^a,b,c   Daneau, Géraldine ^a   Aboud, Said ^d   Vercauteren, Gaby H ^e   Urassa, Willy S K ^e   Kestens, Luc ^a,c  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

CD4 count; CD4 ; FACSCount CD4; Pima CD4; Resource limited settings

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BELGIUM; BLOOD SAMPLING; CAPILLARY BLOOD; CD4 LYMPHOCYTE COUNT; CD4 T CELL COUNT TEST; CLINICAL ASSESSMENT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ACCURACY; MULTICENTER STUDY; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; TANZANIA; VENOUS BLOOD;

ADULT; AGED; AGED, 80 AND OVER; BELGIUM; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TANZANIA; YOUNG ADULT;

EID: 84904459933     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000214     Document Type: Article

References (51)

1. Mellors JW, Munoz A, Giorgi JV, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med. 1997;126:946-954.
2. O'Gorman MR, Zijenah LS. CD4 T cell measurements in the management of antiretroviral therapy-a review with an emphasis on pediatric HIV-infected patients. Cytometry B Clin Cytom. 2008;74(suppl 1): S19-S26.
3. World Health Organization. Technical brief on CD4 technologies (Mai 2010). 2010.
4. Mandy FF, Nicholson JK, McDougal JS. Guidelines for performing single-platform absolute CD4+ T-cell determinations with CD45 gating for persons infected with human immunodeficiency virus. Centers for Disease Control and Prevention. MMWR Recomm Rep. 2003;52:1-13.
5. Mandy F, Janossy G, Bergeron M, et al. Affordable CD4 T-cell enumeration for resource-limited regions: a status report for 2008. Cytometry B Clin Cytom. 2008;74(suppl 1):S27-S39.
6. World Health Organization. Techniques de numération des lymphocytes T CD4: information technique. 2004.
7. Strauss K, Hannet I, Engels S, et al. Performance evaluation of the FACSCount System: a dedicated system for clinical cellular analysis. Cytometry. 1996;26:52-59.
8. Pattanapanyasat K, Sukapirom K, Kowawisatsut L, et al. New BD FACSCount CD4 reagent system for simultaneous enumeration of percent and absolute CD4 T-lymphocytes in HIV-1-infected pediatric patients. Cytometry B Clin Cytom. 2008;74(suppl 1):S98-S106.
9. Predictive value of absolute CD4 cell count for disease progression in untreated HIV-1-infected children. AIDS. 2006;20:1289-1294.
10. Balakrishnan P, Solomon S, Mohanakrishnan J, et al. A reliable and inexpensive EasyCD4 assay for monitoring HIV-infected individuals in resource-limited settings. J Acquir Immune Defic Syndr. 2006;43:23-26.
11. Cassens U, Gohde W, Kuling G, et al. Simplified volumetric flow cytometry allows feasible and accurate determination of CD4 T lymphocytes in immunodeficient patients worldwide. Antivir Ther. 2004;9:395-405.
12. Dieye TN, Vereecken C, Diallo AA, et al. Absolute CD4 T-cell counting in resource-poor settings: direct volumetric measurements versus beadbased clinical flow cytometry instruments. J Acquir Immune Defic Syndr. 2005;39:32-37.
13. Dieye TN, Diaw PA, Daneau G, et al. Evaluation of a flow cytometry method for CD4 T cell enumeration based on volumetric primary CD4 gating using thermoresistant reagents. J Immunol Methods. 2011; 372:7-13.
14. Fryland M, Chaillet P, Zachariah R, et al. The Partec CyFlow Counter could provide an option for CD4+ T-cell monitoring in the context of scaling-up antiretroviral treatment at the district level in Malawi. Trans R Soc Trop Med Hyg. 2006;100:980-985.
15. Kandathil AJ, Kannangai R, David S, et al. Comparison of Microcapillary cytometry technology and flow cytometry for CD4+ and CD8+ T-cell Estimation. Clin Diagn Lab Immunol. 2005;12:1006-1009.
16. Lynen L, Teav S, Vereecken C, et al. Validation of primary CD4 gating as an affordable strategy for absolute CD4 counting in Cambodia. J Acquir Immune Defic Syndr. 2006;43:179-185.
17. Manasa J, Musabaike H, Masimirembwa C, et al. Evaluation of the Partec flow cytometer against the BD FACSCalibur system for monitoring immune responses of human immunodeficiency virus-infected patients in Zimbabwe. Clin Vaccin Immunol. 2007;14:293-298.
18. Mbopi-Keou FX, Mion S, Sagnia B, et al. Validation of a singleplatform, volumetric, CD45-assisted PanLeucogating Auto40 flow cytometer to determine the absolute number and percentages of CD4 T cells in resource-constrained settings using Cameroonian patients' samples. Clin Vaccin Immunol. 2012;19:609-615.
19. Pattanapanyasat K, Phuang-Ngern Y, Sukapirom K, et al. Comparison of 5 flow cytometric immunophenotyping systems for absolute CD4+ T-lymphocyte counts in HIV-1-infected patients living in resourcelimited settings. J Acquir Immune Defic Syndr. 2008;49:339-347.
20. Wade D, Diaw PA, Daneau G, et al. CD4 T-Cell enumeration in a field setting: evaluation of CyFlow counter using the CD4 easy count kit-Dry and Pima CD4 systems. PLoS One. 2013;8:e75484.
21. Diaw PA, Daneau G, Coly AA, et al. Multisided evaluation of a point-ofcare instrument for CD4+ T-cell enumeration using venous and fingerprick blood: the PIMA CD4. J Acquir Immune Defic Syndr. 2011;58: e103-e111.
22. Glencross DK, Coetzee LM, Faal M, et al. Performance evaluation of the Pima point-of-care CD4 analyser using capillary blood sampling in field tests in South Africa. J Int AIDS Soc. 2012;15:3.
23. Jani IV, Sitoe NE, Chongo PL, et al. Accurate CD4 T-cell enumeration and antiretroviral drug toxicity monitoring in primary healthcare clinics using point-of-care testing. AIDS. 2011;25:807-812.
24. Manabe YC, Wang Y, Elbireer A, et al. Evaluation of portable point-ofcare CD4 counter with high sensitivity for detecting patients eligible for antiretroviral therapy. PLoS One. 2012;7:e34319.
25. Mtapuri-Zinyowera S, Chideme M, Mangwanya D, et al. Evaluation of the PIMA point-of-care CD4 analyzer in VCT clinics in Zimbabwe. J Acquir Immune Defic Syndr. 2010;55:1-7.
26. Sukapirom K, Onlamoon N, Thepthai C, et al. Performance evaluation of the Alere PIMA CD4 test for monitoring HIV-infected individuals in resource-constrained settings. J Acquir Immune Defic Syndr. 2011;58: 141-147.
27. Cheng X, Irimia D, Dixon M, et al. A microchip approach for practical label-free CD4+ T-cell counting of HIV-infected subjects in resourcepoor settings. J Acquir Immune Defic Syndr. 2007;45:257-261.
28. Li X, Breukers C, Ymeti A, et al. Clinical evaluation of a simple image cytometer for CD4 enumeration on HIV-infected patients. Cytometry B Clin Cytom. 2010;78:31-36.
29. Logan C, Givens M, Ives JT, et al. Performance evaluation of the MBio Diagnostics point-of-care CD4 counter. J Immunol Methods. 2013;387: 107-113.
30. Rodriguez WR, Christodoulides N, Floriano PN, et al. A microchip CD4 counting method for HIV monitoring in resource-poor settings. Plos Med. 2005;2:e182.
31. UNITAID. HIV/AIDS diagnostic technology landscape. 2013.
32. Rowley CF. Developments in CD4 and viral load monitoring in resourcelimited settings. Clin Infect Dis. 2014;58:407-412.
33. World Health Organization. Antiretroviral therapy for HIV infection in infants and children: towards universal access. Recommendations for a Public Health Approach. 2010 revision. 2010.
34. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. 2013.
35. Herbert S, Edwards S, Carrick G, et al. Evaluation of PIMA point-of-care CD4 testing in a large UK HIV service. Sex Transm Infect. 2012;88:413-417.
36. Broughton PM, Gowenlock AH, McCormack JJ, et al. A revised scheme for the evaluation of automatic instruments for use in clinical chemistry. Ann Clin Biochem. 1974;11:207-218.
37. Chesher D. Evaluating assay precision. Clin Biochem Rev. 2008;29(suppl 1): S23-S26.
38. Denny TN, Gelman R, Bergeron M, et al. A North American multilaboratory study of CD4 counts using flow cytometric panLeukogating (PLG): a NIAID-DAIDS Immunology Quality Assessment Program Study. Cytometry B Clin Cytom. 2008;74(suppl 1):S52-S64.
39. Schnizlein-Bick CT, Spritzler J, Wilkening CL, et al. Evaluation of Tru- Count absolute-count tubes for determining CD4 and CD8 cell numbers in human immunodeficiency virus-positive adults. Site Investigators and the NIAID DAIDS New Technologies Evaluation Group. Clin Diagn Lab Immunol. 2000;7:336-343.
40. Passing H, Bablok. A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I. J Clin Chem Clin Biochem. 1983;21:709-720.
41. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-310.
42. Pollock MA, Jefferson SG, Kane JW, et al. Method comparison-a different approach. Ann Clin Biochem. 1992;29(pt 5):556-560.
43. Scott LE, Galpin JS, Glencross DK. Multiple method comparison: statistical model using percentage similarity. Cytometry B Clin Cytom. 2003;54:46-53.
44. Myer L, Daskilewicz K, McIntyre J, et al. Comparison of point-of-care versus laboratory-based CD4 cell enumeration in HIV-positive pregnant women. J Int AIDS Soc. 2013;16:18649.
45. Morawski BM, Meya DB, Boulware DR. Accuracy of pima point-of-care CD4 analyzer in routine use in public health clinics in Uganda. J Acquir Immune Defic Syndr. 2013;63:e113-e115.
46. Thakar M, Mahajan B, Shaikh N, et al. Utility of the point of care CD4 analyzer, PIMA, to enumerate CD4 counts in the field settings in India. AIDS Res Ther. 2012;9:26.
47. Mwau M, Adungo F, Kadima S, et al. Evaluation of PIMA(R) point of care technology for CD4 T Cell enumeration in Kenya. PLoS One. 2013; 8:e67612.
48. Holstad MM, DiIorio C, McCarty F. Adherence, sexual risk, and viral load in HIV-infected women prescribed antiretroviral therapy. AIDS Patient Care STDS. 2011;25:431-438.
49. Reynolds SJ, Makumbi F, Nakigozi G, et al. HIV-1 transmission among HIV-1 discordant couples before and after the introduction of antiretroviral therapy. AIDS. 2011;25:473-477.
50. Shete A, Thakar M, Abraham PR, et al. A review on peripheral blood CD4+ T lymphocyte counts in healthy adult Indians. Indian J Med Res. 2010;132:667-675.
51. Bekele Y, Mengistu Y, de Wit TR, et al. Timing of blood sampling for CD4 T-cell counting influences HAART decisions. Ethiop Med J. 2011; 49:187-197.